Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

930 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.
Przuntek H, Bittkau S, Bliesath H, Büttner U, Fuchs G, Glass J, Haller H, Klockgether T, Kraus P, Lachenmayer L, Müller D, Müller T, Rathay B, Sgonina J, Steinijans V, Teshmar E, Ulm G, Volc D. Przuntek H, et al. Among authors: fuchs g. Arch Neurol. 2002 May;59(5):803-6. doi: 10.1001/archneur.59.5.803. Arch Neurol. 2002. PMID: 12020263 Clinical Trial.
Diagnostic aspects of early Parkinson's disease.
Müller T, Fuchs G, Hahne M, Klein W, Schwarz M. Müller T, et al. Among authors: fuchs g. J Neurol. 2006 Aug;253 Suppl 4:IV29-31. doi: 10.1007/s00415-006-4006-2. J Neurol. 2006. PMID: 16944354
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, Müller T, Kupsch A, Henningsen H, Oertel WH, Fuchs G, Kuhn W, Niklowitz P, Koch R, Herting B, Reichmann H; German Coenzyme Q(10) Study Group. Storch A, et al. Among authors: fuchs g. Arch Neurol. 2007 Jul;64(7):938-44. doi: 10.1001/archneur.64.7.nct60005. Epub 2007 May 14. Arch Neurol. 2007. PMID: 17502459 Clinical Trial.
Which factors influence therapeutic decisions in Parkinson's disease?
Baas H, Fuchs G, Gemende I, Hueber R, Lachenmayer L, Schneider E, Schoenberger B, Werner M. Baas H, et al. Among authors: fuchs g. J Neurol. 2002 Oct;249 Suppl 3:III/49-52. doi: 10.1007/s00415-002-1310-3. J Neurol. 2002. PMID: 12522573 Review.
Genetic analysis of immunomodulating factors in sporadic Parkinson's disease.
Krüger R, Hardt C, Tschentscher F, Jäckel S, Kuhn W, Müller T, Werner J, Woitalla D, Berg D, Kühnl N, Fuchs GA, Santos EJ, Przuntek H, Epplen JT, Schöls L, Riess O. Krüger R, et al. Among authors: fuchs ga. J Neural Transm (Vienna). 2000;107(5):553-62. doi: 10.1007/s007020070078. J Neural Transm (Vienna). 2000. PMID: 11072751
930 results